期刊文献+

贝那普利 美托洛尔治疗充血性心力衰竭 被引量:2

在线阅读 下载PDF
导出
摘要 目的评价贝那普利和美托洛尔联用治疗充血性心力衰竭的疗效。方法贝那普利和美托洛尔联用治疗慢性充血性心力衰竭30例作为治疗组,单用贝那普利治疗者20例为对照组。以超声心动图比较治疗前及治疗4周后,左室收缩和舒张末期容量(ESV和EDV)及左室射血分数(LVEF)。结果两组治疗前后的LVFE均明显升高,且治疗组LVEF、EDV明显优于对照组。结论贝那普利和美托洛尔联用治疗慢性充血性心力衰竭安全有效。
机构地区 汝州市中医院
出处 《医药论坛杂志》 2006年第5期66-67,共2页 Journal of Medical Forum
  • 相关文献

参考文献4

二级参考文献23

  • 1Stewart S, Maclntyre K, Macleod MM, et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J,2001, 22:209-217.
  • 2Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J,2001,22:1527-1560.
  • 3Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J,2003,145:S18-S25.
  • 4Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail,2001,3:283-291.
  • 5Coletta AP, Cleland JG, Freemantle N, et al. Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM. Eur J Heart Fail,2003,5:697-704.
  • 6Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005, 352:225-237.
  • 7Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005,352:1539-1549.
  • 8Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet,2004 ,364:141-148.
  • 9Arnold JM, Yusuf S, Young J, et al. HOPE Investigators. Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation,2003,107:1284-1290.
  • 10Fox KM. European trial on reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet,2003,362:782-788.

共引文献207

同被引文献7

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部